Flagship explainer
What drives ABVC BioPharma, Inc.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$7.9M | FY2025 |
| |
| Income before tax | −$8.4M | FY2025 |
|
| Operating income | −$7.2M | FY2025 |
|
| $296000 | FY2025 |
| |
| Ending assets | $21.1M | FY2025 |
|
| Beginning assets | $7.5M | FY2024 |
|
| $11.1M | FY2025 |
| |
| $1.2M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001213900-26-023063